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Research
Long­term exposure to ambient air pollution 
has been associated with cardiovascular mor­
bidity and mortality in numerous epidemio­
logic studies (Dockery et al. 1993; Miller et al. 
2007; Pope et al. 2004), but the mechanisms 
responsible for its observed effects remain 
poorly understood (Bhatnagar 2006). A vari­
ety of hypothesized pathways have been impli­
cated in human and animal studies, including 
an effect of air pollution on endothelial func­
tion and vascular tone, autonomic function, 
thrombosis, blood pressure, and oxidative 
stress. Recent reviews of the studies impli­
cating these pathways have been published 
(Brook 2007; Mills et al. 2009; Pope and 
Dockery 2006; Simkhovich et al. 2008).
Among studies that have demonstrated 
increased cardiovascular morbidity and mor­
tality associated with air pollution exposures, 
traffic­related air pollution in particular has 
been increasingly recognized as an important 
source of cardiovascular disease (CVD)­
modifying exposures. Recent work in the 
Multi­Ethnic Study of Atherosclerosis 
(MESA) has demonstrated a link between 
close (< 50 m) residential major roadway 
proximity, an indicator of high traffic expo­
sure, and higher left ventricular mass (LVM) 
index (Van Hee et al. 2009). Increased LVM 
is associated with the subsequent development 
of depressed ejection fraction (Drazner et al. 
2004), and left ventricular hypertrophy is 
associated with heart failure, arrhythmia, and 
sudden cardiac death (Bluemke et al. 2008; 
Levy et al. 1990). Efforts to elucidate the ways 
in which air pollution might relate to higher 
LVM may provide not only greater under­
standing of the underlying CVD process itself 
but also potential strategies for intervention.
Several genes and genetic pathways have 
been noted to have important functions in 
the postulated mechanisms responsible for the 
impact of air pollution on CVD. Components 
of the renin–angiotensin system, including 
angiotensinogen (AGT), angiotensin­convert­
ing enzyme (ACE), and type 1 angiotensin II 
receptor (AGTR1) genes, have well­described 
impacts on inflammation, blood pressure, 
and vasoconstriction (Gradman 2009) that 
are mediated in part via G protein–coupled 
receptor kinases (GRKs), including GRK4 
(Felder and Jose 2006). Prostaglandin­
endoperoxide synthase 1 and 2 genes (PTGS1 
and PTGS2), as well as 15­lipoxygenase gene 
(ALOX15), play important roles in vascular 
inflammation and oxidative stress that leads 
to CVD (Dogné et al. 2005; Mochizuki and 
Kwon 2008; Wittwer and Hersberger 2007). 
Endothelin­1 (EDN1) is a potent vasocon­
strictor that activates signaling pathways lead­
ing to atherosclerosis (Ivey et al. 2008). The 
beta­2 adrenergic receptor (ADRB2) affects 
cardiac autonomic function and the develop­
ment of heart failure (Triposkiadis et al. 2009). 
Together with ALOX15, vascular endothelial 
growth factors A and B (VEGFA and VEGFB) 
promote vascular growth, which contributes to 
the development of atherosclerotic plaque and 
plaque instability (Mochizuki and Kwon 2008; 
Sluimer and Daemen 2009). Toll­like recep­
tor 4 (TLR4) affects the inflammatory response 
that influences initiation and progression of 
atherosclerosis (Pasterkamp et al. 2004).
Address  correspondence  to  V.C.  Van  Hee, 
Occupational  and  Environmental  Medicine 
Program, University of Washington, Harborview 
Medical Center, Box 359739, 325 9th Ave., Seattle, 
WA 98104 USA. Telephone: (206) 744­9398. Fax: 
(206) 744­9935. E­mail: vvanhee@u.washington.edu
Supplemental  Material  is  available  online 
(doi:10.1289/ehp.0901535 via http://dx.doi.org/).
This study was supported by National Heart, 
Lung, and Blood Institute contracts N01­HC­95159 
through N01­HC­95165, N01­HC­95169, R01 
HL077612, HL070151, HL071205, HL071251­
52,  HL071258­59,  and  T32HL07902;  U.S. 
Environmental Protection Agency Science to 
Achieve Results grant RD831697; and National 
Institute of Environmental Health Sciences grants 
P50ES015915, P30ES07033, and K24ES013195.
The authors declare they have no actual or potential 
competing   financial interests.
Received 2 October 2009; accepted 22 March 2010.
Common Genetic Variation, Residential Proximity to Traffic Exposure,  
and Left Ventricular Mass: The Multi-Ethnic Study of Atherosclerosis
Victor C. Van Hee,1,2 Sara D. Adar,1,3 Adam A. Szpiro,4 R. Graham Barr,5,6 Ana Diez Roux,7 David A. Bluemke,8 
Lianne Sheppard,1,4 Edward A. Gill,2 Hossein Bahrami,9,10 Christina Wassel,11 Michele M. Sale,12  
David S. Siscovick,2,3 Jerome I. Rotter,12 Stephen S. Rich,13 and Joel D. Kaufman1,2
1Department of Environmental and Occupational Health Sciences, 2Department of Medicine, 3Department of Epidemiology, and 
4Department of Biostatistics, University of Washington, Seattle, Washington, USA; 5Department of Medicine, and 6Department of 
Epidemiology, Columbia University Medical Center, New York, New York, USA; 7Department of Epidemiology, University of Michigan, 
Ann Arbor, Michigan, USA; 8Radiology and Imaging Sciences, National Institutes of Health, Department of Health and Human 
Services, Bethesda, Maryland, USA; 9Department of Epidemiology, Johns Hopkins School of Public Health, Baltimore, Maryland, USA; 
10Department of Cardiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA; 11Department of Epidemiology, University of 
Minnesota, Minneapolis, Minnesota, USA; 12Department of Medical Genetics, Cedars-Sinai Medical Center, Los Angeles, California, USA; 
13Center for Public Health Genomics, University of Virginia, Charlottesville, Virginia, USA
Ba c k g r o u n d: Elevated left ventricular mass (LVM) is a strong predictor of negative cardiovascular 
outcomes, including heart failure, stroke, and sudden cardiac death. A relationship between close 
(< 50 m compared with > 150 m) residential proximity to major roadways and higher LVM has 
previously been described, but the mechanistic pathways that are involved in this relationship are 
not known. Understanding genetic factors that influence susceptibility to these effects may provide 
insight into relevant mechanistic pathways.
oB j e c t i v e: We set out to determine whether genetic polymorphisms in genes affecting vascular 
and autonomic function, blood pressure, or inflammation influence the relationship between traffic 
proximity and LVM.
Me t h o d s : This was a cross­sectional study of 1,376 genotyped participants in the Multi­Ethnic 
Study of Atherosclerosis, with cardiac magnetic resonance imaging performed between 2000 and 
2002. The impact of tagged single­nucleotide polymorphisms (tagSNPs) and inferred haplotypes in 
12 candidate genes (ACE, ADRB2, AGT, AGTR1, ALOX15, EDN1, GRK4, PTGS1, PTGS2, TLR4, 
VEGFA, and VEGFB) on the relationship between residential proximity to major roadways and LVM 
was analyzed using multiple linear regression, adjusting for multiple potential confounders.
re s u l t s: After accounting for multiple testing and comparing homozygotes, tagSNPs in the 
type 1 angiotensin II receptor (AGTR1, rs6801836) and arachidonate 15­lipoxygenase (ALOX15, 
rs2664593) genes were each significantly (q < 0.2) associated with a 9–10% difference in the asso­
ciation between residential proximity to major roadways and LVM. Participants with suboptimal 
blood pressure control demonstrated stronger interactions between AGTR1 and traffic proximity.
co n c l u s i o n s : Common polymorphisms in genes responsible for vascular function, inflamma­
tion, and oxidative stress appear to modify associations between proximity to major roadways and 
LVM. Further understanding of how genes modify effects of air pollution on CVD may help guide 
research efforts into specific mechanistic pathways.
key w o r d s : AGTR1, ALOX15, cardiac structure, cardiac MRI, gene–environment interactions, left 
ventricular mass, traffic, air pollution. Environ Health Perspect 118:962–969 (2010).  doi:10.1289/
ehp.0901535 [Online 22 March 2010]Gene–traffic interactions and left ventricular mass
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We conducted a study to determine 
whether polymorphisms in these prespecified 
genes involved in the regulation of vascular 
tone, blood pressure, autonomic function, 
and oxidative stress modify the previously 
observed relationship between proximity to 
major roadways and LVM in MESA.
Materials and Methods
Population and sampling. MESA is a prospec­
tive cohort study designed to examine the pro­
gression of subclinical CVD; it enrolled 6,814 
men and women 44–85 years of age who were 
free of clinical CVD at entry. The partici­
pants were recruited from six U.S. communi­
ties: Baltimore, Maryland; Chicago, Illinois; 
Forsyth County, North Carolina; Los Angeles 
County, California; Northern Manhattan, 
New York; and St. Paul, Minnesota. Details 
of the sampling, recruitment, and data collec­
tion have been previously reported (Bild et al. 
2002). A subcohort of 2,880 unrelated MESA 
subjects were selected for genetic studies from 
subjects who gave informed consent for DNA 
extraction and use in genetic studies and had 
sufficient DNA available for this study. Priority 
was given to subjects who were included in a 
1,000­person subset of participants with addi­
tional blood biomarker meas  urements, supple­
mented by random selection from remaining 
participants to fulfill balanced ethnic group 
representation (720 African American, 720 
Hispanic, 720 Chinese, and 720 European 
American) and equality by sex.
For the present study, we included all 
participants in the genetic study database 
(n = 2,847) who underwent cardiac magnetic 
resonance imaging (MRI) at examination 1 
(n = 2,152), had accurate address information 
for exposure assignment, and represented the 
groups with the greatest contrast in traffic 
proximity exposure (living within 50 m com­
pared with ≥ 150 m from a major roadway) 
and the largest LVM association from our 
prior study (Van Hee et al. 2009), leaving 
1,376 participants for analysis.
Study procedures. Medical history, 
address, anthropometric measurements, physi­
cal examination, and laboratory data for the 
present study were taken from the first exami­
nation of the MESA cohort, July 2000 to 
August 2002 (Bild et al. 2002). Information 
about age, sex, ethnicity, and medical history 
were obtained by questionnaires administered 
at the screening and the first examination. 
Institutional review boards at all participating 
centers approved the protocol, ensuring con­
formance with the Declaration of Helsinki, 
and all participants gave informed consent.
Geocoding and exposure assessment. 
Participants’ residential addresses were assigned 
geographic coordinates using ArcGIS 9.1 
software (ESRI, Redlands, CA) in conjunc­
tion with the Dynamap/2000 street network 
and geocoding database (Tele Atlas, Boston, 
MA). We calculated proximity to traffic by 
measuring the distance from geocoded home 
address to the nearest major roadway (inter­
state, state, or county highway or major arte­
rial), with a maximum search radius of 150 m. 
Exposure groups were divided into 0–50 m 
and > 150 m from the nearest major road­
way. These two groups were chosen a priori   
based upon the results of our prior study, 
which demonstrated the largest associations 
between traffic exposure and LVM compar­
ing the group residing within 50 m of a major 
roadway with the group living > 150 m away 
(Van Hee et al. 2009). This exposure contrast 
is consistent with the observed distribution of 
near­roadway air pollutants, with many pollut­
ants rapidly approaching background levels by 
150–200 m from large roadways (Hoek et al. 
2002; Smargiassi et al. 2005; Zhu et al. 2002).
Cardiac MRI imaging. LVM was obtained 
by cardiac MRI. Images were acquired by 
1.5­T MRI scanners (Signa LX and CVi, GE 
Healthcare, Waukesha, WI; and Somatom 
Vision and Sonata, Siemens Medical Solutions, 
Berlin, Germany) using a protocol previously 
described (Natori et al. 2006). All MRI data 
were submitted to the MESA MRI Reading 
Center at Johns Hopkins Hospital for central­
ized processing using MASS software, version 
4.2 (Medis, Leiden, Netherlands).
DNA extraction. DNA was extracted from 
peripheral leukocytes isolated from packed cells 
of anticoagulated blood by use of a commer­
cially available DNA isolation kit (Puregene; 
Gentra Systems, Minneapolis, MN). The DNA 
was quantified by determination of absorbance 
at 260 nm followed by PicoGreen analysis 
(Molecular Probes, Inc., Eugene, OR). Two 
vials of DNA were stored per participant at 
–70°C and subsequently aliquoted for use.
Selection of candidate genes. Twelve 
genes were selected from among genotyped 
MESA candidate genes: ACE, ADRB2, AGT, 
AGTR1, ALOX15, EDN1, GRK4, PTGS1, 
PTGS2, TLR4, VEGFA, and VEGFB. Genes 
were chosen based upon hypothesized mecha­
nisms responsible for the effect of air pollut­
ants on LVM as described above.
Selection of single­nucleotide poly­
morphisms. Single­nucleotide polymorphisms 
(SNPs) were selected in candidate gene loci 
according to the following criteria: a) within 
the proximal and distal 10­kb regions 5´   
and 3´ to the given candidate gene (NCBI 
Build 35; National Center for Biotechnology 
Information 2004); b) compatibility with the 
Illumina GoldenGate technology (Fan et al. 
2006) as determined by the Assay Design Tool 
(TechSupport, Illumina, San Diego, CA); and 
c) minor allele frequency (MAF) > 0.05 or 
a tag (r2 > 0.8) for another SNP with MAF 
> 0.05 as determined by applying the multi­
locus or “aggressive” “Tagger” option of 
Haploview version 3 (Barrett et al. 2005) using 
International HapMap project data for CEPH 
(Caucasian) and Yoruban populations (release 
19; International HapMap Consortium 2003). 
In some cases a complete set of tagged SNPs 
(tagSNPs) for a given candidate gene was not 
possible because of these competing criteria. 
Additional SNPs were added from a) LDselect 
analysis of resequencing information from the 
SeattleSNPs project if available (Carlson et al. 
2004; Nickerson 2003); b) nonsynonymous 
SNPs from dbSNP release 124 (National 
Center for Biotechnology Information 2005); 
and c) SNPs with prior reports of association 
proposed by a MESA investigator.
Selection of ancestry informative markers.   
Ancestry informative markers (AIMs) were 
selected from an Illumina proprietary SNP 
database to maximize the difference in allele 
frequencies between any pair of ethnic 
groups: European American versus African 
American, European American versus Chinese 
American, and African American versus 
Chinese American. Additional markers infor­
mative for Mexican­American ancestry were 
selected from published lists (Choudhry et al. 
2006; Collins­Schramm et al. 2004). All sub­
jects were genotyped for the 199 total AIMs 
selected for inclusion. Principal components 
of AIMs were calculated using Stata (version 
10.1; StataCorp LP, College Station, TX).
Genotyping. Genotyping was performed 
by Illumina Genotyping Services (Illumina 
Inc.) using their proprietary GoldenGate 
assay. Of 150 SNPs initially typed, 11 failed 
quality control measures and were excluded. 
After excluding 24 SNPs with an overall 
MAF < 2%, 115 common tagSNPs in the 
12 genes under study were chosen for the 
present analysis. We inferred haplotypes using 
the expectation­maximization algorithm of 
PHASE 2.1 (Stephens and Scheet 2005). 
Haplotype uncertainty was estimated using 
the diplotype probability. Within a gene, 
haplotypes with probability­weighted fre­
quencies < 2.5% were grouped together in a 
gene­specific haplotype bin assigned “others.”   
A total of 85 common haplotypes were inves­
tigated. Supplemental Material, Table 1 
(doi:10.1289/ehp.0901535.), summarizes the 
tagSNPs and haplotypes examined.
Data quality control. Illumina performed 
initial quality control to identify samples 
and SNPs that failed genotyping according 
to proprietary protocols and sporadic failed 
genotypes with GenCall (Illumina) quality 
score < 99.99%. After removal of failed SNPs 
and samples, the genotype calling rate was 
99.93%, with maximum missing data rate per 
sample of 2.1% and maximum missing per 
SNP of 4.98%. The cohort genetic data was 
checked for cryptic sample duplicates and dis­
crepancies in genetically predicted sex (using 
X markers) versus study database reported sex. Van Hee et al.
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Samples with unresolved duplicate and sex 
discrepancies were removed from the genetic 
study database.
Statistical methods. We produced descrip­
tive statistics using frequencies and percent­
ages for categorical variables and means and 
SDs for continuous variables. The distribu­
tions of covariates were compared across 
proximity to major roadway categories and 
log­transformed LVM using analysis of vari­
ance methods for continuous variables and 
chi­square tests for categorical variables. 
SNP genotype frequencies were tested for 
race­stratified Hardy–Weinberg equilib­
rium using exact tests. Race­stratified linkage 
disequilibrium was assessed for each of the 12 
genes under analysis.
A total of 1,139 participants had no miss­
ing data on any outcomes or covariates. An 
initial analysis was performed without impu­
tation and using models with reduced sets 
of covariates that required no imputation. 
Subsequently, iterative multiple imputation 
procedures were performed using switching 
regression and chained equations for the full 
1,376 participants, including data on coti­
nine levels for 1,082 of 1,376 participants to 
impute secondhand smoking data (Royston 
2007). This process resulted in the full sample 
of 1,376 adults with some imputed values. 
The regression analysis was repeated on the 
imputed sample, yielding overall results simi­
lar to those estimated initially. All reported 
findings are from the imputed data set because 
the precision of the estimates is improved by 
the increased sample size, and the full data set 
is less likely to be subject to bias (Greenland 
and Finkle 1995; van der Heijden et al. 2006).
We first performed SNP­specific analyses 
to examine interactions between SNPs and 
very close (< 50 m) residential proximity to 
major roadway for log­transformed LVM. 
We then performed haplotype analyses to also 
examine interactions between haplotypes and 
very close proximity to major roadways for 
LVM. We fitted linear, additive (1 degree of 
freedom) models separately for each individual 
SNP (coded 0, 1, and 2 for minor allele cop­
ies) and for each haplotype (coded 0, 1, and 
2 for number of haplotype copies). Diplotype 
probabilities were used as weights in the haplo­
type analyses clustered on participant identi­
fier. Individual F­tests for the product term 
of SNP × proximity < 50 m and haplotype × 
proximity < 50 m were calculated to obtain 
p­values for interactions. The false discovery 
rate (FDR) correction (q­value) was used to 
account for multiple testing (115 tests in each 
SNP model and 85 haplotypes in each haplo­
type model) (Hochberg and Benjamini 1990; 
Storey 2002). A q­value of 0.2, corresponding 
to a 20% FDR, was selected as a threshold for 
acceptable level of significance (Smith et al. 
2007). To account for potential confounding 
by population stratification, we adjusted for 
the first five principal components of AIMs 
in all analyses. All models were additionally 
adjusted for age, sex, height, and weight.
Additional potential confounders for 
the full model, chosen a priori based upon a 
prior study of the relationship between traffic 
exposure and LVM (Van Hee et al. 2009), 
and results of the initial descriptive analyses 
included household income, highest educa­
tional attainment level, systolic and diastolic 
blood pressure, medication use, low­ (LDL) 
and high­ (HDL) density­lipoprotein choles­
terol, physical activity, alcohol use, smoking 
and pack­year history of smoking, secondhand 
smoke exposure, and diabetes status by fast­
ing blood glucose criteria or medication for 
diabetes. Medication use was modeled using 
indicator variables for ACE inhibitors,   
angiotensin­receptor blockers (ARBs), diuret­
ics, beta­blockers, lipid­lowering medications, 
aspirin, nonsteroidal antiinflammatory drugs 
(NSAIDs), and cyclooxygenase (COX) inhibi­
tors. Because several of these covariates (par­
ticularly blood pressure) may lie in the causal 
biological pathway between the exposure and 
outcome, and as a sensitivity analysis, we also 
examined several partially adjusted models 
with reduced sets of covariates. Confidence 
intervals (CIs) were calculated at an alpha value 
Characteristic n (%) 
Distance to major roadway (m)
> 150 919 (66.8)
< 50 457 (33.2)
Site/center
Baltimore, MD 179 (13.0)
Chicago, IL 229 (16.6)
Los Angeles, CA 444 (32.3)
New York, NY 205 (14.9)
St. Paul, MN 150 (10.9)
Winston-Salem, NC 169 (12.3)
Sex
Female 722 (52.5)
Race/ethnicity
African American 322 (23.4)
Chinese 394 (28.6)
European American 352 (25.6)
Hispanic 308 (22.4)
Age (years)
44–54 454 (33.0)
55–64 397 (28.9)
65–74 386 (28.1)
75–84 139 (10.1)
Highest education level completed
Less than high school 266 (19.3)
Completed high school or some college 437 (31.8)
Technical school or associate degree 178 (12.9)
Bachelor’s degree 255 (18.5)
Graduate/professional degree 237 (17.2)
Gross family income
< $25,000 463 (33.6)
$25,000 to $49,999 347 (25.2)
$50,000 to $74,999 223 (16.2)
$75,000 to $99,999 120 (8.7)
> $100,000 183 (13.3)
BMI (kg/m2)
< 23 256 (18.6)
23–27.5 540 (39.2)
27.6–40 559 (40.6)
> 40 21 (1.5)
Fasting blood glucose (mg/dL)
< 100 813 (59.1)
100–125 381 (27.7)
> 125, untreated 56 (4.1)
> 125, treated 124 (9.0)
Cigarette smoking status
Never 791 (57.5)
Former 415 (30.2)
Current 170 (12.4)
Table 1. Population characteristics at baseline examination: MESA, 2002 (n = 1,376).
Characteristic n (%) 
Pack-years smoking
< 10 1,016 (73.8)
10–19.9 123 (8.9)
≥ 20 230 (16.7)
Secondhand smoke exposure (hr/week)
0 768 (55.8)
1 158 (11.5)
2–5 130 (9.5)
6–10 50 (3.6)
> 10 92 (6.7)
Alcohol use
Never 367 (26.7)
Former 287 (20.9)
Current 709 (51.5)
Blood pressure (mmHg)
< 130/85 863 (62.7)
130–139/85–89 193 (14)
140–159/90–99 241 (17.5)
> 159/99 79 (5.7)
Hypertension medication 473 (34.4)
Angiotensin type 2 antagonists 45 (3.3)
Combinations of angiotensin II 
antagonists plus diuretics
26 (1.9)
ACE inhibitors without diuretics 146 (10.6)
ACE inhibitors with diuretics 11 (0.8)
Any lipid-lowering medication 209 (15.2)
Aspirin 295 (21.4)
Beta-blockers without diuretics 123 (8.9)
Beta-blockers with diuretics 8 (0.6)
COX-2 inhibitors 89 (6.5)
NSAIDs 183 (13.3)
LDL (mg/dL)
< 100 390 (28.3)
100–129 535 (38.9)
130–159 320 (23.3)
160–189 94 (6.8)
> 189 17 (1.2)
HDL (mg/dL)
< 40 291 (21.1)
40–59 768 (55.8)
> 59 315 (22.9)
LVMa
Grams 140.2 ± 37.8
Log LVM 4.9 ± 0.3
Multiple imputation using all data including measured cotinine levels for 1,082 participants was used to impute miss-
ing covariates (179 secondhand smoke values, 40 income level measures, 20 LDL and 2 HDL values, 13 alcohol use and 
7 pack-years smoking values, and 3 educational level, 3 exercise level, and 2 diabetes status measures).
aMean ± SD.Gene–traffic interactions and left ventricular mass
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of 0.05. We then conducted several sensitivity 
analyses, including stratification by race, blood 
pressure, and medication use. Subpopulation 
effects in all interaction models were calculated 
using linear combinations of predictors in each 
model (lincom command in Stata).
Data were analyzed using Stata and R (ver­
sion 2.9; R Development Core Team 2009). 
The authors had full access to the data and take 
responsibility for the integrity of the data. 
Results
Descriptive statistics. Table 1 indicates the 
overall distribution of participant characteris­
tics. The 1,376 participants in this study 
ranged in age from 44 to 84 years. Although all 
MESA participants were free of clinical CVD 
at baseline, a substantial percentage had cardiac 
risk factors (Table 1). On bivariate analyses, 
race, sex, site, antihypertensive medication use, 
body mass index (BMI), secondhand smoke 
exposure, and income were at least moder­
ately associated (p < 0.2) with proximity to 
major roadway (data not shown). African 
Americans, Hispanics, women, participants 
in New York and Baltimore, those on antihy­
pertensive medication and specifically ACE 
inhibitor therapy, and those with higher BMIs, 
higher secondhand smoke exposures, and lower 
income tended to reside nearer to major road­
ways. Associations between LVM and nearly 
every covariate were strong. African­American 
race, St. Paul study site, male sex, younger age, 
hypertension, antihypertensive medication use, 
BMI, blood pressure, cigarette smoke expo­
sure, fasting blood glucose, income, education, 
lower HDL cholesterol, and higher height and 
weight were all associated with higher LVM on 
bivariate analysis. After adjustment for height 
and weight, LVM was positively associated 
with age (data not shown).
We noted no significant deviations from 
race­stratified Hardy–Weinberg equilibrium, 
such as those associated with geno  typing 
error, on exact testing at an alpha level of 
0.05 with Bonferroni correction for 115 tests. 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0901535), lists the selected SNPs and 
inferred haplotypes for this study, with the 
frequencies (for tagSNPs) or probability­
weighted frequencies (for inferred haplotypes) 
of each. The principal components of AIMs 
showed generally good discrimination between 
self­categorized races, with Hispanics demon­
strating the most diverse ancestry and show­
ing some ancestral overlap with other racial 
groups [Supplemental Material, Figure 2 
(doi:10.1289/ehp.0901535)].
Primary SNP interaction   analyses. All 
SNP–traffic proximity interaction models 
tested demonstrated significant evidence of 
interactions for two of the 12 genes tested, 
ALOX15 and AGTR1 [Table 2; see also 
Supplemental Material, Figure 1 (doi:10.1289/
ehp.0901535)]. The minimally adjusted 
model (model 1) containing only study site 
and principal components of AIMs, age, sex, 
height, and weight showed significant (q < 0.2) 
evidence of interactions for rs389566 and 
rs6801836 in AGTR1, with a 9% (95% CI, 
2–16%) difference in the impact of traffic prox­
imity (< 50 m residential proximity compared 
with > 150 m residential proximity) on LVM 
comparing homozygotes for rs389566 and an 
11% (95% CI, 3–19%) difference comparing 
homozygotes for rs6801836. The full model 
(model 5) comprising all covariates showed sig­
nificant evidence of inter  actions for rs2664593 
in ALOX15 [10% (95% CI, 2–19%) difference 
in the association between traffic proximity and 
LVM comparing homozygotes] and rs6801836 
in AGTR1 [9% (95% CI, 2–17%) difference 
comparing homozygotes]. Complete results of 
all SNP–roadway proximity interaction tests 
for all genes are included in Supplemental 
Material, Table 2 (doi:10.1289/ehp.0901535).
Table 2. SNP–traffic interactions on LVM, top four interactions by model: percent change in LVM asso-
ciated with close (< 50 m) residential proximity to major roadway compared with > 150 m, by tagSNP 
homozygote.
Model/Gene tagSNP
p-Value for 
interaction Genotype
Percent difference  
in LVM associated with  
traffic proximity (95% CI)
Model 1: study site, age, sex, AIMs, height, weight
AGTR1 rs389566 0.001* TT 6.3 (2.1 to 10.8)
AA –2.9 (–5.5 to –0.2)
AGTR1 rs6801836 0.001* GG 8.6 (3.2 to 14.3)
AA –2.5 (–5 to –0.1)
ALOX15 rs2664593 0.011 CC 7.5 (1.3 to 14.2)
GG –1.6 (–3.9 to 0.7)
AGTR1 rs385338 0.012 CC 5.5 (0.8 to 10.5)
GG –1.9 (–4.4 to 0.6)
Model 2: model 1 + diabetes, lipids, education, income, alcohol use, and physical activity
AGTR1 rs389566 0.001* TT 6.1 (1.8 to 10.5)
AA –2.9 (–5.5 to –0.2)
AGTR1 rs6801836 0.001* GG 8.5 (3 to 14.2)
AA –2.6 (–5 to –0.1)
ALOX15 rs2664593 0.013 CC 7.3 (1 to 13.9)
GG –1.7 (–4 to 0.7)
AGTR1 rs385338 0.018 CC 5.1 (0.4 to 10.1)
GG –1.9 (–4.4 to 0.7)
Model 3: model 2 + smoking status, pack-years, and secondhand smoke exposure
AGTR1 rs389566 0.002* TT 6 (1.7 to 10.4)
AA –2.8 (–5.4 to –0.2)
AGTR1 rs6801836 0.001* GG 8.2 (2.8 to 14)
AA –2.5 (–5 to –0.1)
ALOX15 rs2664593 0.013 CC 7.3 (1 to 13.9)
GG –1.7 (–4 to 0.7)
AGTR1 rs385338 0.019 CC 5.1 (0.3 to 10)
GG –1.9 (–4.4 to 0.7)
Model 4: model 3 + blood pressure
AGTR1 rs6801836 0.002* GG 7.7 (2.6 to 13.1)
AA –2 (–4.3 to 0.4)
ALOX15 rs2664593 0.004* CC 8.3 (2.4 to 14.7)
GG –1.5 (–3.7 to 0.8)
AGTR1 rs389566 0.007 TT 5.1 (1.1 to 9.3)
AA –2 (–4.5 to 0.6)
ALOX15 rs7220870 0.013 AA 7.3 (1.4 to 13.5)
CC –1.3 (–3.5 to 1)
Model 5 (a priori model): model 4 + medication use
ALOX15 rs2664593 0.003* CC 8.5 (2.6 to 14.9)
GG –1.7 (–3.9 to 0.5)
AGTR1 rs6801836 0.004* GG 7 (1.9 to 12.4)
AA –1.9 (–4.2 to 0.4)
ALOX15 rs7220870 0.008 AA 7.5 (1.7 to 13.8)
CC –1.5 (–3.7 to 0.7)
AGTR1 rs389566 0.013 TT 4.6 (0.6 to 8.8)
AA –1.9 (–4.4 to 0.6)
Model 1 (minimally adjusted model) contains each tagSNP, proximity to roadway categories, interaction terms between 
SNP and proximity, study site, age, sex, height, weight, and the principal components of AIMs. Model 2 contains covari-
ates from model 1, plus additional CVD risk factors (diabetes, lipids, education, income, alcohol use, and physical activ-
ity) except smoking. Model 3 contains covariates from model 2 plus smoking. Model 4 adds blood pressure to model 3. 
Model 5, the fully adjusted model, adds medication use (ACE inhibitors, ARBs, diuretics, beta-blockers, lipid-lowering 
medications, aspirin, NSAIDs, and COX inhibitors) to model 4. 
*Interactions meeting q-value threshold for statistical significance (q < 0.2). Van Hee et al.
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In all cases of significant interactions, the 
minor allele represented the deleterious allele. 
The MAF of polymorphisms conferring appar­
ent susceptibility to traffic proximity ranged 
from 23% (rs6801836) to 33% (rs389566) 
for AGTR1 and from 19% (rs2664593) to 
21% (rs7220870) for ALOX15. The top 
four SNPs representing greatest evidence for 
interaction overall in models 4 and 5 con­
sist of one group of two adjacent tagSNPs 
on ALOX15 (rs2664593 at position 7 and 
rs7220870 at position 8) and two nearby 
tagSNPs on AGTR1 (rs389566 at position 
10 and rs6801836 at position 12). Figure 1 
represents the relative location of each evalu­
ated tagSNP on the two genes with signifi­
cant findings. In the Supplemental Material, 
Figures 3 and 4 (doi:10.1289/ehp.0901535) 
show linkage disequilibrium maps for each 
racial group for ALOX15 and AGTR1. SNP 
positions 7 and 8 in ALOX15 and 10–12 in 
AGTR1 show strong linkage disequilibrium 
across all racial groups.
Haplotype interaction results. After rare 
haplotypes were collapsed into a single cate­
gory, remaining haplotypes containing the 
deleterious SNPs in AGTR1 and ALOX15 had 
low probability­weighted haplotype frequen­
cies [3% for AGTR1­E and AGTR1­F, 9% 
for ALOX15­C, and 3% for ALOX15­I; see 
Supplemental Material, Table 1 (doi:10.1289/
ehp.0901535)]. Despite this reduced power 
to detect interactions for haplotypes com­
pared with individual SNPs, we found sig­
nificant (q < 0.2) interactions for AGTR1­F 
after taking into account multiple testing. 
In model 5, proximity to roadway had no 
significant association with LVM in individu­
als without this haplotype, whereas the pres­
ence of a single haplotype conferred an 8.6% 
(95% CI, 3.0–14.6%) positive difference in 
LVM (p­value for interaction = 0.002) associ­
ated with close (< 50 m) proximity to a major 
roadway compared with living farther away 
(> 150 m). All five models showed consistent 
impacts on susceptibility, with the presence 
of AGTR1­F showing increased susceptibil­
ity to traffic proximity on LVM. Complete 
results of all haplotype–roadway proximity 
interaction tests for all genes and all models 
are included in Table 3 of the Supplemental 
Material (doi:10.1289/ehp.0901535).
Sensitivity analyses. As described above and 
shown in Table 2 and Supplemental Material, 
Figure 1 (doi:10.1289/ehp.0901535), results 
were not particularly sensitive to model 
selection. To investigate the impact of racial 
structure on the findings, we performed 
stratification by race (using a three­way inter­
action among SNP, proximity to roadway, 
and race) for the two significant (q < 0.2) 
inter  active SNPs in the full model, an analy­
sis that includes adjustment for the principal 
components of AIMs (Figure 2). Although we 
found no significant evidence of a three­way 
inter  action between rs6801836 (p­value for 
three­way interaction = 0.7) or rs2664593 
(p­value for three­way interaction = 0.6), road­
way proximity, and race, the overall results 
suggest less pronounced gene–environment 
interactions for African Americans compared 
with other racial groups.
We also explored stratification by blood 
pressure categories [Seventh Report of the 
Joint National Committee on Prevention, 
Detection, Evaluation, and Treatment of 
High Blood Pressure (JNC VII) categories for 
all participants, binary optimal/  suboptimal 
blood pressure, binary hypertensive/not 
hypertensive] (Chobanian et al. 2003) and 
use of medications important in the renin­
  angiotensin system or inflammatory pathways 
(ACE inhibitors, ARBs, aspirin, and NSAIDs) 
to determine whether these were groups par­
ticularly susceptible to this interaction. Among 
these analyses, we found significant evidence 
of interaction among rs6801836, proximity to 
traffic, and optimal versus suboptimal blood 
pressure categories. The difference in the LVM 
change associated with roadway proximity for 
individuals with greater numbers of the delete­
rious (G) allele in rs6801836 was significantly 
larger among individuals with suboptimal 
blood pressure by JNC VII criteria (systolic 
blood pressure ≥ 120 mmHg or diastolic 
blood pressure ≥ 80 mmHg, n = 732 partici­
pants) than among those with optimal blood 
pressure (p­value for three­way interaction = 
0.05; Figure 3). We found no other significant 
three­way interactions for the medication use 
or blood pressure categories tested.
Discussion
We found significant evidence of gene–traffic 
interactions in MESA, with polymorphisms 
in AGTR1 and ALOX15, genes important in 
vascular function and inflammation/oxidative 
stress, associated with substantial alterations 
in the association between traffic proximity 
and LVM. Exploratory analyses additionally 
revealed that the interaction associated with 
Figure 1. Percent difference in LVM associated with living within 50 m of a major roadway compared with living > 150 m away (fully adjusted model), by all tagSNP 
homozygotes in ALOX15 (A) and AGTR1 (B). SNPs are arranged in their positional order along the chromosome. Data points indicate estimates for individuals 
homozygous for the minor allele (light blue) and for the major allele (dark blue). Numbers represent the number of participants in the significant genotype categories.   
Error bars are 95% CIs. 
*Interactions meeting q-value threshold for statistical significance (q < 0.2).
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the common polymorphism in the AGTR1 
gene (rs6801836) is larger for individuals with 
suboptimal blood pressure (> 120 mmHg 
systolic or > 80 mmHg diastolic) than for 
those with optimal blood pressure control. 
Haplotype analyses, although likely under­
powered in this setting, provided additional 
support for SNP findings in AGTR1.
AGTR1 is a well­known regulator of blood 
pressure and common target of specific phar­
macologic intervention (ARB) in hypertension. 
The specific tagSNP locus (rs6801836) found 
to demonstrate interactive effects here has 
not yet been observed to show main effects in 
MESA or other studies (Bahrami et al. 2008). 
However, polymorphisms in AGTR1, and par­
ticularly the A1166C polymorphism (rs5186), 
have been associated with inflammation 
(Suchankova et al. 2009) and left ventricular 
hypertrophy (Smilde et al. 2007). Additionally, 
an association between the A1166C polymor­
phism and hypertension has been observed in 
a number of studies, although results have been 
somewhat inconsistent (Mottl et al. 2008). 
A possible explanation for the inconsistencies 
observed in these studies is the presence of 
unexamined interactive effects with environ­
mental factors, such as those observed in the 
present analysis. Our observation that blood 
pressure and the identified polymorphism in 
AGTR1 appear to interact to produce suscep­
tibility to the hypertrophic effects of traffic 
exposure is consistent with the well­known 
role of AGTR1 in the regulation of blood pres­
sure and provides support to the hypothesis 
that the effect of air pollution is mediated by 
genes involved in blood pressure regulation. 
This observation also suggests an important 
role of both genetic and other environmental 
factors (in this case, factors that contribute to 
blood pressure) in modulating the effects of air 
pollution on CVD.
The protein encoded by ALOX15 is an 
oxidizing enzyme that can produce reactive 
lipid hydroperoxides within the vasculature. 
Experimental and human epidemiologic stud­
ies have demonstrated a range of contrasting 
effects of ALOX15 on CVD, and its role at 
present is not fully understood (Mochizuki 
and Kwon 2008; Wittwer and Hersberger 
2007). Variants specifically at the rs2664593 
locus in the 5´ promoter region of the gene 
have previously (but inconsistently) been asso­
ciated with carotid atherosclerosis and have 
been shown to interact in the relationship 
between carotid wall thickness and insulin 
resistance (Bevan et al. 2009; McCaskie et al. 
2008). In MESA, this specific SNP locus has 
not shown main effects on LVM (Bahrami H, 
unpublished observations).
Both ALOX15 and AGTR1 are likely to 
play important roles in inflammation, one 
of the primary putative mechanisms for the 
impact of air pollution on CVD and also an 
important mechanism involved in the devel­
opment of left ventricular hypertrophy. These 
genes’ apparent interaction with air pollution 
to produce increases in LVM could suggest 
an important role of vascular inflammation 
in the pathogenesis of traffic­related air pollu­
tion–induced CVD more generally.
Linkage disequilibrium mapping of 
AGTR1 and ALOX15 in these analyses sug­
gests that regions near to tagSNPs rs6801836 
on AGTR1 and rs2664593 on ALOX15 are 
responsible for the interactions seen in this 
study. Finer mapping of ALOX15 and AGTR1 
in these regions may help identify the specific 
polymorphism associated with these results.
Because the MESA cohort has four dis­
tinct racial groups, it represents a unique 
opportunity to examine gene–environment 
interactions in a multiethnic population. 
Analyses performed in this heterogeneous 
group must take into account the important 
issue of potential confounding by popula­
tion stratification. To account for this issue 
of multiple ethnic groups that also vary in 
structure by site, we adjusted for both study 
site and the principal components of AIMs. 
We additionally examined three­way interac­
tions with race in an analysis that included 
both site and AIMs and observed no evidence 
of substantial confounding or effect modi­
fication by race. Although we found no sig­
nificant evidence overall of modification of the 
interactions by race, the finding that African 
Americans show apparently less pronounced 
interactions (Figure 2) bears further investiga­
tion. It is possible that additional relationships 
with other underlying genetic factors that pre­
dispose African Americans to known higher 
LVM (gene–gene interactions) may play a role 
in attenuating this particular interaction.
Few studies to date have examined gene–
environment interactions in the cardiovascu­
lar health effects of air pollutants (Baccarelli 
et al. 2008; Chahine et al. 2007; Park et al. 
2006; Schwartz et al. 2005). Of those stud­
ies, most have focused on individual functional 
Figure 2. Race-stratified percent difference in LVM associated with living within 50 m of a major roadway compared with living > 150 m away (fully adjusted 
model) for tagSNPs showing significant evidence of interactive effects: rs2664593 in ALOX15 (A) and rs6801836 in AGTR1 (B). Error bars are 95% CIs. 
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Figure 3. Percent difference in LVM associated 
with living within 50 m of a major roadway com-
pared with living > 150 m away, by blood pressure 
(BP) categories (optimal vs. suboptimal) according 
to JNC VII criteria and rs6801836 (AGTR1) geno-
type. Model comprises SNP, proximity to roadway 
categories, interaction terms between SNP and 
proximity, study site, age, sex, height, weight, prin-
cipal components of AIMs, diabetes, lipids, educa-
tion, income, alcohol use, physical activity, and 
smoking. Error bars are 95% CIs. 
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polymorphisms or individual candidate genes, 
with few exceptions (Peters et al. 2007; Ren 
et al. 2010). This is the first study to explore 
multiple polymorphisms in pathways of inter­
est with the goal of furthering understanding 
of how air pollution affects cardiac structure 
specifically.
This study has several limitations. We can­
not rule out the possibility that a portion of 
the findings may have arisen by chance. We 
chose an FDR of 0.2 as a measure of statistical 
significance in this study, as have other studies 
(Smith et al. 2007). By definition, the choice 
of an FDR threshold to account for multiple 
testing controls for an expected proportion of 
incorrectly rejected null hypotheses. Future 
studies examining these relationships in addi­
tional cohorts will be necessary to replicate 
and confirm these findings. As have other 
recent studies of the health impacts of air pol­
lution, we used a relatively coarse indicator 
of exposure to traffic­related air pollution, 
advantages and disadvantages of which have 
been described in more detail previously (Van 
Hee et al. 2009). The exposure misclassifica­
tion produced by such methods may lead to 
bias in estimating the effects in subpopula­
tions and overall and may adversely affect 
standard error estimates (Gryparis et al. 2009; 
Kim et al. 2009; Szpiro et al. 2009). Because 
of the chosen exposure metric, this study is 
unable to distinguish between interactions 
produced by specific components of traffic­
related air pollutants or even non­air pollut­
ants related to traffic (e.g., noise; for more 
detail, see Van Hee et al. 2009). Ongoing 
work will help disentangle these traffic­related 
influences on health.
Although the interactions observed in 
this study are relatively modest, in this same 
data set a 10­mmHg increase in systolic blood 
pressure (one of the factors known to be most 
important in the development of increased 
LVM) is associated with only an adjusted 3% 
higher LVM. Given that individuals homozy­
gous for the deleterious alleles show a 7–8% 
difference in LVM associated with close prox­
imity to a major roadway, and given the high 
minor allele frequencies and high prevalence 
of close residential proximity to a major road­
way seen here, the public health impacts of 
these findings are potentially significant.
In our prior analysis of the relationship 
between proximity to roadways and VM (Van 
Hee et al. 2009), we reported results using 
an untransformed LVM index (rather than 
log­transformed LVM adjusted for height and 
weight) as the dependent variable in order to 
make the results more accessible to the pri­
mary audience. As we described in that report, 
the preferred statistical methods for regression 
analysis avoid the use of ratios such as the 
LVM index to prevent spurious correlation 
(Kronmal 1993). For this reason, and to meet 
the more stringent requirements of popula­
tion association studies, which require that the 
outcome be approximately normally distrib­
uted rather than only the residuals (Balding 
2006), we have used log LVM adjusted for 
height and weight in this report. For compar­
ison purposes, we have reported the results of 
our prior study with the same parameteriza­
tion used here in Table 4 of the Supplemental 
Material (doi:10.1289/ehp.0901535).
In addition to replication of these find­
ings specifically, human studies such as phar­
macologic intervention trials may further 
understanding of these potentially modifiable 
genetic pathways. Although this study was 
not powered to detect three­way interactions 
among genes, air pollution, and medication 
use, the observation that the presence of opti­
mal blood pressure may attenuate the effect 
of genes and air pollution on cardiovascular 
outcomes is a provocative one.
As described above, the mechanisms 
responsible for the effects of air pollutants on 
CVD remain uncertain, although several stud­
ies have implicated inflammation and oxidative 
stress, as well as impaired vascular function. 
Modification of the effect of traffic exposures 
on LVM by genes involved in inflamma­
tory response and vascular function suggests 
that individuals with genetically determined 
impaired handling of inflammation and altered 
vascular responses have greater susceptibility to 
these effects. This finding lends further support 
to pathways involving these mechanisms.
Conclusions
SNPs in genes responsible for vascular func­
tion, inflammation, and oxidative stress 
(AGTR1 and ALOX15) modify associations 
between proximity to major roadways and 
LVM. Further understanding of how genes 
modify effects of air pollution on CVD may 
help guide research efforts into specific mecha­
nistic pathways.
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